Search

Lance Boling (SDSU) and colleagues tested 117 consumable compounds (like toothpaste, Stevia, aspartame) for their ability to induce prophages from four bacterial species. They found that certain compounds induced prophages (some in a specie

A new monthly podcast called Superbugs Unplugged covers antimicrobial resistance news (and even covers phages, in episode two!).

Aurélie Mathieu (Université Paris-Saclay) and colleagues have published an exciting new paper in Nature Communications: they isolated 150 E. coli phages from fecal samples from 1-year-old infants. Then they analyzed the host range of the ph

This week, we bring you an interview with Danish Malik, Senior Lecturer at Loughborough University. He tells us about current challenges with phage manufacturing, including what phage companies need to think about, and how academic-commerci

Australia is becoming a hotspot for phage therapy research and innovation. In this in-depth Sydney Morning Herald feature, Jeremy Barr describes his role in Tom Patterson's phage therapy case (Jeremy now runs his own phage research lab at M

Could destroying phages after they've found their target help make phages work more like drugs? In a new PNAS paper, Huan Peng (UC Santa Barbara) and colleagues describe how they've conjugated phages to gold nanorods, which can "cook" nearb

A new crAssphage paper by Tanvi Honap (University of Oklahoma) and colleagues shows that crAssphage prevalence correlates with more industrialized lifestyles. Paper | News Article

BCM Tailor Labs is a new initiative out of Baylor College of Medicine focused on phage therapy.

Attention phage companies with interests in addressing animal health challenges! You can apply here to showcase your solution at the Animal Microbiome and Nutritional Health Congress in Chicago Mar 3-4, 2020. (Apparently most companies who'

A new article in STAT News by Eric Boodman (one of our favourite phage journalists!) talks about how a phage has been found that kills Mallory Smith's infective Burkholderia cepacia isolate. In Mallory's honour, the phage has been named BCM

BCM Tailor Labs is a new initiative out of Baylor College of Medicine focused on phage therapy.

Professor Craig Winstanley, Dr. Jo Fothergill and Dr. Rachel Floyd at the University of Liverpool are seeking an enthusiastic and motivated postdoctoral microbiologist to join a project entitled "Phage therapy to treat bacterial urinary tra

Dr. Matt Daugherty at UCSD is hiring a lab manager. From Twitter: "If you'd like to work for a few years (e.g. before grad school or med school) in beautiful San Diego, and interested in host-pathogen evolution, virology or biochemical mech

We know a lot about how phages expand their host ranges, but not so much about how they shrink them. A new Scientific Reports paper by Tzvi Holtzman (Israel Institute for Biological Research) and colleagues shows how T7 phage limits futile

A new crAssphage paper by Tanvi Honap (University of Oklahoma) and colleagues shows that crAssphage prevalence correlates with more industrialized lifestyles. Paper | News Article

Dr. Matt Daugherty at UCSD is hiring a lab manager. From Twitter: "If you'd like to work for a few years (e.g. before grad school or med school) in beautiful San Diego, and interested in host-pathogen evolution, virology or biochemical mech

Could destroying phages after they've found their target help make phages work more like drugs? In a new PNAS paper, Huan Peng (UC Santa Barbara) and colleagues describe how they've conjugated phages to gold nanorods, which can "cook" nearb

We know a lot about how phages expand their host ranges, but not so much about how they shrink them. A new Scientific Reports paper by Tzvi Holtzman (Israel Institute for Biological Research) and colleagues shows how T7 phage limits futile

Professor Craig Winstanley, Dr. Jo Fothergill and Dr. Rachel Floyd at the University of Liverpool are seeking an enthusiastic and motivated postdoctoral microbiologist to join a project entitled "Phage therapy to treat bacterial urinary tra

This week, we bring you an interview with Michele Wales, founder of the legal firm InHouse Patent Counsel. She tells us about the unique challenges phage companies face in protecting their IP, and why she's optimistic about what's to come.